Nav: Home

UC Davis researcher advocates ending Medicare coverage of controversial mammography tool

September 28, 2015

(SACRAMENTO, Calif.) -- A costly tool used on nearly all mammograms does not increase cancer detection rates and should no longer be covered by Medicare, argues Joshua Fenton, a family physician and comparative effectiveness researcher in an editorial published online today in the Journal of the American Medical Association Internal Medicine.

Fenton's editorial responds to a study published in the same issue that announces findings from the largest study ever on computer-aided detection (CAD), a tool approved by the Food and Drug Administration nearly 20 years to help radiologists interpret screening mammograms by automatically marking potentially suspicious spots for further radiological review.

The study was led by Constance D. Lehman, currently director of breast imaging and co-director of the Avon Comprehensive Breast Evaluation Center at Massachusetts General Hospital in Boston, who conducted the research while at the University of Washington in Seattle. UC Davis Dean's Professor in Biostatistics Diana Miglioretti was senior author on the study, which found that the device used with mammography did not improve the accuracy of diagnosis, and that its use may in fact result in missed cancers.

"The study by Leyman, et al. provides evidence that CAD yields no clear benefits in a large, diverse U.S. sample of women undergoing digital mammography," Fenton writes. "Thus we should question whether society should continue to pay for CAD use."

Using data from the Breast Cancer Surveillance Consortium, Leyman's observational study looked at 323,973 women undergoing digital screening mammography in diverse U.S. practices between 2003 and 2009. Mammograms were interpreted by 271 radiologists from 66 facilities. Tumor registry data identified 3,159 breast cancers within one year of screening.

For the study, the researchers analyzed the mammography performance, including its sensitivity (the proportion of cancers positively detected), specificity (the proportion of accurate negative findings), the number of cancers detected during mammography and those discovered within 12 months of a negative mammogram finding. They found that screening performance was not improved with CAD on any one of the assessed metrics. In fact, they found that sensitivity was significantly decreased for mammograms interpreted with CAD among radiologists who interpreted results with and without the added technology.

In the editorial, Fenton, who also has published several research articles about the merits of CAD, said any potential positive effects of CAD may be undetectable in the context of digital mammography, which may improve the radiologist's interpretation regardless of CAD.

Since Medicare agreed to cover the cost of CAD in 2000, its use has surged to over 90 percent of U.S. mammograms. Leyman estimated that its prolific use adds up to more than $400 million per year, or $1 of every $10,000 spent on healthcare.

Miglioretti, who was senior author on the Lehman study and has a joint appointment as a senior investigator at Group Health Research Institute, said the results of the CAD research suggest that federal regulators and payers should base coverage determinations on facts.

"We need to make sure there is stronger evidence for new technologies before we start paying for them," she said, "and before people are charged extra money for them."
-end-


University of California - Davis Health System

Related Mammography Articles:

Mammography screening: Only 1 in 3 women is well-informed
Only one in three women participating in Germany's mammography screening program is well-informed about it: the higher the level of education, the greater the chance of women making an informed decision.
Menopausal status a better indicator than age for mammography frequency
In a study conducted to inform American Cancer Society breast cancer screening guidelines, UC Davis researcher Diana L.
Computer-aided mammography detection not associated with improved accuracy
Computer-aided detection in screening mammography was not associated with improved diagnostic accuracy in a study that analyzed results from a large Breast Cancer Surveillance Consortium database of digital screening mammograms, according to an article published online by JAMA Internal Medicine.
Mammography benefits overestimated
An in-depth review of randomized trials on screening for breast, colorectal, cervical, prostate and lung cancers, published in the Journal of the Royal Society of Medicine, shows that the benefits of mammographic screening are likely to have been overestimated.
3-D mammography improves cancer detection in dense breasts
A major new study has found that digital breast tomosynthesis, also known as 3-D mammography, has the potential to significantly increase the cancer detection rate in mammography screening of women with dense breasts.
New device may ease mammography discomfort
Researchers have developed a new device that may result in more comfortable mammography for women.
Screening with tomosynthesis and mammography is cost-effective
Adding tomosynthesis to biennial digital mammography screening for women with dense breasts is likely to improve breast cancer detection at a reasonable cost relative to biennial mammography screening alone, according to a new study.
Mammography benefits women over 75
Mammography-detected breast cancer is associated with a shift to earlier stage diagnosis in older women, subsequently reducing the rate of more advanced, difficult-to-treat cases, according to a new study.
The mammography dilemma
A comprehensive review of 50 years' worth of international studies assessing the benefits and harms of mammography screening suggests that the benefits of the screening are often overestimated, while harms are underestimated.
Digital mammography reduces recall and biopsy rates
Population-based screening with full-field digital mammography is associated with lower recall and biopsy rates than screen film mammography, suggesting that full-field digital mammography may reduce the number of diagnostic workups and biopsies that do not lead to diagnosis of breast cancer, according to a new study.

Related Mammography Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".